Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy responseYan Mei, Guangshuai Jia, Yiyi Li et al.|Nature Cancer|2023Cited by 219
Sirpα on tumor-associated myeloid cells restrains antitumor immunity in colorectal cancer independent of its interaction with CD47Chunliu Huang, Wenfei Jin, Xuefei Wang et al.|Nature Cancer|2024Cited by 94
SIRPα: A key player in innate immunityYongyi Feng, Jun Chen, Chunliu Huang et al.|European Journal of Immunology|2023Cited by 23
PSGL-1 is a phagocytosis checkpoint that enables tumor escape from macrophage clearanceCheng Zhong, Jun Chen, Lixiang Wang et al.|Science Immunology|2025Cited by 19
AMPK-dependent Parkin activation suppresses macrophage antigen presentation to promote tumor progressionXinyu Wang, Jun Chen, Hongrui Song et al.|Science Advances|2025Cited by 12